Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,633 | 43,218 | 52,800 | 74,740 | 33,283 |
| Receivables | 775 | 1,278 | 2,670 | 739 | 431 |
| Inventories | 564 | N/A | 601 | 1,507 | 1,502 |
| TOTAL | $107,755 | $46,924 | $57,500 | $78,363 | $36,770 |
| Non-Current Assets | |||||
| PPE Net | 2,233 | 2,365 | 2,534 | 2,642 | 2,830 |
| Other Non-Current Assets | 5,734 | 5,597 | 5,498 | 5,327 | 5,060 |
| TOTAL | $7,967 | $7,962 | $8,032 | $7,969 | $7,890 |
| Total Assets | $115,722 | $54,886 | $65,532 | $86,332 | $44,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,258 | 444 | 7,766 | 8,419 | 8,170 |
| Accounts payable and accrued liabilities | 2,194 | 2,588 | 2,020 | 4,013 | 11,878 |
| Accrued Expenses | 14,774 | 13,890 | 14,971 | 22,076 | 20,903 |
| Other current liabilities | 1,099 | 1,424 | 573 | 634 | 619 |
| TOTAL | $20,240 | $19,258 | $26,202 | $36,463 | $41,874 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,880 | 13,575 | 7,023 | 7,007 | 9,193 |
| Deferred Revenues | 915 | 912 | 872 | 1,321 | 304 |
| Other Non-Current Liabilities | 5,266 | 5,473 | 3,204 | 3,356 | 3,585 |
| TOTAL | $18,435 | $19,538 | $10,918 | $10,949 | $13,159 |
| Total Liabilities | $38,675 | $38,796 | $37,120 | $47,412 | $55,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,977 | 57,983 | 42,970 | 42,983 | 28,215 |
| Common Shares | 58 | 43 | 2,220,448 | 2,219,067 | 2,172,061 |
| Retained earnings | -2,199,447 | -2,195,346 | -2,181,080 | -2,169,106 | -2,170,154 |
| Other shareholders' equity | -12,541 | -11,995 | -12,046 | -12,131 | -12,280 |
| TOTAL | $77,047 | $16,090 | $28,412 | $38,920 | $-10,373 |
| Total Liabilities And Equity | $115,722 | $54,886 | $65,532 | $86,332 | $44,660 |